New User? Click here to register

Comment améliorer les stratégies thérapeutiques en radiothérapie des carcinomes in situ dans les sous groupes à bas risque ?

February 11, 2023

Yazid BELKACEMI MD, PhD, Radiotherapist, Creteil, France

Yazid BELKACEMI
MD, PhD, Radiotherapist, Creteil, France

What is the significance of HER2 amplification and how does it affect the use of antibody-drug conjugates (ADCs)?
Joseph GLIGOROV
oncologist, Paris, France
MRI Imaging bone metastatic assessment.

Yvonne MARATOS
Radiologist, Cannes, France
Preoperative assessment with FDG Pet CT scan
Eric ZERBIB
Surgery in Liver BC metastasis.

Rakesh RAI
Surgeon, Dubai, UAE
Premalignant lesions: When to avoid open surgery?
Foucauld CHAMMING’S

Leave a Comment cancel

You must be logged in to post a comment.